Quantcast

Latest NGM Biopharmaceuticals Inc. Stories

2010-10-05 07:00:00

SOUTH SAN FRANCISCO, Calif., Oct. 5 /PRNewswire/ -- NGM Biopharmaceuticals, Inc. (NGM), a privately held biotechnology company dedicated to the discovery and development of novel biotherapeutics for the treatment of Type 2 diabetes and other metabolic diseases, announced today that William J. Rieflin has been named Chief Executive Officer and appointed to NGM's Board of Directors. "We are delighted that Bill will be leading NGM in the next phase of its evolution," said David V. Goeddel,...

2010-03-15 08:00:00

SOUTH SAN FRANCISCO, Calif., March 15 /PRNewswire/ -- NGM Biopharmaceuticals today announced it has closed the first tranche of a $51 million Series B round of financing. The Series B round included The Column Group, Tichenor Ventures, LLC, Prospect Venture Partners, Rho Ventures and other new and Series A investors. With this financing, NGM also announced the appointment of McHenry (Mac) T. Tichenor, Jr., Managing Member of Tichenor Ventures, to the NGM board of directors. NGM has...

2009-10-21 08:00:00

SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire/ -- NGM Biopharmaceuticals, Inc. (NGM), a private company dedicated to the discovery and development of novel biotherapeutics for the treatment of Type 2 diabetes and other metabolic diseases, today announced that Arthur D. Levinson, Ph.D., the Chairman of Genentech's Board of Directors, has been appointed to NGM's Board of Directors. Under Dr. Levinson's leadership as Chairman and Chief Executive Officer from 1995 to 2009, Genentech...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related